ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 39 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $591 | -41.6% | 5,100 | 0.0% | 0.00% | – |
Q4 2022 | $1,012 | +1.2% | 5,100 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | -66.7% | 5,100 | 0.0% | 0.00% | -100.0% |
Q2 2022 | $3,000 | 0.0% | 5,100 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $3,000 | 0.0% | 5,100 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $3,000 | -40.0% | 5,100 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $5,000 | -16.7% | 5,100 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $6,000 | +20.0% | 5,100 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $5,000 | +150.0% | 5,100 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $2,000 | -50.0% | 5,100 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $4,000 | +33.3% | 5,100 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $3,000 | +200.0% | 5,100 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -66.7% | 5,100 | 0.0% | 0.00% | -100.0% |
Q4 2019 | $3,000 | -25.0% | 5,100 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $4,000 | -42.9% | 5,100 | 0.0% | 0.00% | -66.7% |
Q2 2019 | $7,000 | – | 5,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|